| 8:00-8:55 a.m.
|
Registration and Check-In
Exhibits and Posters
Continental Breakfast
|
| 9:00-12:05 p.m. | Session I |
| | Moderators: Frank DellaFera, `81P
President & CEO
Fera Pharmaceuticals Indranil Nandi, Ph.D.
Director
Portfolio, Project and Launch Management Group
Sandoz Inc. |
9:00-9:10 a.m. |
Opening Remarks
|
| | Robert A. Mangione, `77P, `79GP, `93PD, `99Ed.D.
Professor and Dean
College of Pharmacy and Health Sciences
St. John’s University
|
| 9:10-9:40 a.m. | Innovation and Value Enhancement in Drug Product
Development:
The Role of Academia in Meeting Present and Future
Challenges
Distinguished Guest Presentation |
| |
David R. Taft, Ph.D.
Professor and Dean
Arnold & Marie Schwartz College of Pharmacy and Health
Sciences
Long Island University
|
9:45-10:25 a.m. | Keynote Presentation: |
| | Reduce Cost and Timelines with the 505(b)(2) Drug
Approval Process |
| |
Kenneth V. Phelps
President and CEO
Camargo Pharmaceutical Services
|
10:25-10:40 a.m. | Coffee Break |
10:40-11:20 a.m.
|
Repurposing Drugs
|
| |
Mahendra G. Shah, `77GP, `85Ph.D.
Partner, Vivo Ventures
Former Chairman and CEO, Nextwave Pharmaceuticals
|
| 11:25-12:05 p.m. | Innovation Strategies to Drug Repositioning and Life
Cycle Optimization |
| |
Sesha Neervannan, Ph.D.
Vice President, Pharmaceutical Development Allergan
|
12:05 – 1:30 p.m. | Mid-Day Break |
| | Lunch, Exhibits, Jarowski Scholarship Award
Presentation
|
1:30- 4:30 p.m. | Session II |
| | Moderators Dileep Bhagwat, `79GP, MBA, `83Ph.D.
Senior Vice President of
Pharmaceutical Development
EpiCept Corporation
Navnit H. Shah, `73GP, `81Ph.D.
Distinguished Research Leader
Pharmaceutical & Analytical R&D
Hoffman LaRoche
|
| 1:30-2:10 p.m. | Fixed Combination Drug Delivery System: Formulation and
Technology Consideration |
| |
Salah U. Ahmed, `85GP, `90Ph.D.
President and CEO
Abon Pharmaceuticals
|
| 2:15-2:55 p.m. | Application of Nanocrystal Technology in Development of
Value Enhanced Products |
| |
Gary Liversidge, Ph.D.
Chief Technology Officer and Vice President
Alkermes, Inc.
|
| 3:00-3:40 p.m. | The Captisol® Experience: A Drug Product Enabling
Technology |
| |
J. D. Pipkin, Ph.D.
Sr. Director, New Product Development
Ligand Pharmaceuticals
|
| 3:45-4:25 p.m. | Incivek – Pharmaceutical Development of an Enabling
Technology |
| |
Tapan Sanghvi, Ph.D.
Scientific Fellow
Vertex Pharmaceuticals
|
| 4:25-4:30 p.m. | Closing Remarks |
| | Louis D. Trombetta, Ph.D.
Professor and Chair
Department of Pharmaceutical Sciences, St. John’s
University
|
| 4:30-5:30 p.m. | Evening Reception |
| | Industrial Pharmacy Laboratory Ribbon Cutting & Net
working Reception
St. Albert’s Hall, B02
|
| | |
| | |
| | |
| | |
| | |